Skip to Content

Supemtek solution for injection in pre-filled syringe Trivalent influenza vaccine (recombinant, prepared in cell culture)

Licence status
Authorised: 30/03/2026
Active substances
Influenza A virus subtype H1N1 haemagglutinin, recombinant, Influenza A virus subtype H3N2 haemagglutinin, recombinant, Influenza B virus Victoria lineage haemagglutinin, recombinant
Dosage Form
Solution for injection in pre-filled syringe
Licence number
EU/1/26/2016/001-006
Licence holder
Sanofi Winthrop Industrie

Licence information

ATC code
J07BB02 influenza, inactivated, split virus or surface antigen
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to medical prescription. In accordance with Article 114 of Directive 2001/83/EC, the official batch release will be undertaken by a state laboratory or a laboratory designated for that purpose.
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
30/03/2026